Development of Respimat® Soft Mist™ Inhaler and its clinical utility in respiratory disorders
Richard N Dalby1, Joachim Eicher2, Bernd Zierenberg21Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, USA; 2Boehringer Ingelheim, Ingelheim, GermanyAbstract: The Respimat® Soft Mist™ Inhaler (SMI) (Boehringer Ingelheim International GmbH, Ingelh...
Guardado en:
Autores principales: | Dalby RN, Eicher J, Zierenberg B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d5a22fa4d674a1282abc4c2e6b073c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review
por: VanDevanter DR, et al.
Publicado: (2011) -
Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent
por: Jonathan Bridges, et al.
Publicado: (2008) -
Updates on the use of ureteral stents: focus on the Resonance® stent
por: Thomas MT Turk, et al.
Publicado: (2010) -
An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®
por: Estella M Davis, et al.
Publicado: (2010) -
Prefilled certolizumab pegol (Cimzia®) syringes for self-use in the treatment of rheumatoid arthritis
por: J Rosa, et al.
Publicado: (2010)